Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration (original) (raw)
Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients
Dr. Abdulaziz S Al Obaid
Antimicrobial Agents and Chemotherapy, 2016
View PDFchevron_right
Dosing guidelines for fluconazole in patients with renal failure
Vincent Launay-vacher
Nephrology Dialysis Transplantation, 2003
View PDFchevron_right
Pharmacokinetics of fluconazole in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration
Michael Roberts
International journal of antimicrobial agents, 2015
View PDFchevron_right
Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg
M. Hoffmann
Nephrology Dialysis Transplantation, 2005
View PDFchevron_right
The Pharmacokinetic Profile of Voriconazole During Continuous High-volume Venovenous Hemofiltration in a Critically Ill Patient
Philippe Montravers
Therapeutic Drug Monitoring, 2008
View PDFchevron_right
Pharmacokinetic study of intravenous posaconaozle in a critically ill patient with multiple organ failure
Porpon Rotjanapan
Australasian Medical Journal
View PDFchevron_right
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study
Claude Martin
Critical Care, 2015
View PDFchevron_right
Pharmacokinetic study of intravenous posaconaozle in a critically ill patient with multiple organ failure: A case report
Porpon Rotjanapan
Australasian Medical Journal, 2017
View PDFchevron_right
Empirical Fluconazole versus Placebo for Intensive Care Unit Patients
Susan McCormick Hadley
Annals of Internal Medicine, 2008
View PDFchevron_right
Pharmacokinetics of fluconazole in people with HIV infection: a population analysis
Andrew McLachlan
British Journal of Clinical Pharmacology, 2003
View PDFchevron_right
Bioavailability of Oral Fluconazole in Critically Ill Abdominal Trauma Patients With and Without Abdominal Wall Closure: a Randomized Crossover Clinical Trial
Octavio Martinez
The Journal of Trauma: Injury, Infection, and Critical Care, 2007
View PDFchevron_right
In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis
Jeffrey Lipman
Antimicrobial Agents and Chemotherapy, 2015
View PDFchevron_right
Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid
Martin Mayers
Antimicrobial Agents and Chemotherapy, 1994
View PDFchevron_right
HPLC Assay of Fluconazole and Its Application to Patients with Early Septic Shock
Nouf Aloudah
Journal of Liquid Chromatography & Related Technologies, 2005
View PDFchevron_right
Fluconazole Exposure in Plasma and Bile During Continuous Venovenous Hemodialysis
Inès Gana
Therapeutic Drug Monitoring, 2019
View PDFchevron_right
Fluconazole Pharmacokinetics in Burn Patients
Bill Hickerson
Antimicrobial Agents and Chemotherapy, 1998
View PDFchevron_right
Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers
Robert Woestenborghs
Antimicrobial Agents and Chemotherapy, 1986
View PDFchevron_right
Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients
J. Kosterink
Antimicrobial Agents and Chemotherapy, 2021
View PDFchevron_right
Plasma Concentrations of Posaconazole Administered via Nasogastric Tube in Patients in a Surgical Intensive Care Unit
Stefan Höfer
Antimicrobial Agents and Chemotherapy, 2012
View PDFchevron_right
Adjustment of Antimicrobial Dosages for Continuous Venovenous Hemofiltration Based on Patient-Specific Information
T. Zembower
Clinical Infectious Diseases, 2006
View PDFchevron_right
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: A report of 2 cases
Federico Pea
American Journal of Kidney Diseases, 2004
View PDFchevron_right
Pharmacokinetics and pharmacodynamics of anti-infective agents during continuous veno-venous hemofiltration in critically ill patients: Lessons learned from an ancillary study of the IVOIRE trial
Alexandre Ouattara
Journal of Translational Internal Medicine, 2019
View PDFchevron_right
Clinical Pharmacokinetics During Continuous Haemofiltration
Emaad Abdel-rahman
Clinical Pharmacokinetics, 1994
View PDFchevron_right
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration
Florian Thalhammer
Journal of Antimicrobial Chemotherapy, 2007
View PDFchevron_right
Population pharmacokinetics of linezolid in critically ill patients on renal replacement therapy: comparison of equal doses in continuous venovenous haemofiltration and continuous venovenous haemodiafiltration
Benjamin Louart
The Journal of antimicrobial chemotherapy, 2016
View PDFchevron_right
Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients
Ine Vercammen, Pieter Annaert, Katrien Lagrou
Antimicrobial agents and chemotherapy, 2014
View PDFchevron_right
Pharmacokinetics of Posaconazole Administered Orally or by Nasogastric Tube in Healthy Volunteers
Lei Ma
Antimicrobial Agents and Chemotherapy, 2009
View PDFchevron_right
Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects
Maria Caceres
Antimicrobial Agents and Chemotherapy, 2014
View PDFchevron_right
Possible association between high-dose fluconazole and adrenal insufficiency in critically ill patients
Mary Joy Mortiz Deleon
Critical Care Medicine, 2001
View PDFchevron_right
Gender Differences in the Oral Pharmacokinetics of Fluconazole
MIRIAM DEL CARMEN CARRASCO-PORTUGAL
Clinical Drug Investigation, 2007
View PDFchevron_right
Single-dose pharmacokinetics of levofloxacin during continuous veno-venous haemofiltration in critically ill patients
Heidrun Losert
Journal of Antimicrobial Chemotherapy, 2001
View PDFchevron_right
Elimination of fluconazole during continuous renal replacement therapy. An in vitro assessment
Frederic Baud
International Journal of Artificial Organs, 2020
View PDFchevron_right
Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection
Alan Forrest
Antimicrobial Agents and Chemotherapy, 1995
View PDFchevron_right
Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
Florian Thalhammer
Critical Care, 2004
View PDFchevron_right
Pharmacokinetics of single, oral-dose voriconazole in peritoneal dialysis patients
Yeong-Hau Lien
American Journal of Kidney Diseases, 2005
View PDFchevron_right